维普期刊资源整合服务平台（V6.5）

33篇 您的检索式：作者名="Mosnier L"

选中清除导出查看参考文献查看引证文献引用追踪共2页首页上一页第1页下一页末页 /2 跳转

	题名	作者	年代	出处	被引量
1	Novel mechanisms for activatedprotein C cytoprotective activities involving noncanonicalactivation of protease-activated receptor 3显示文摘	Burnier L Mosnier LO	2013	Blood2013，122，5：	1
2	Thrombinactivatable fibrinolysis inhi-bitor (TAFI, Plasma procarboxypeptidase B, procarboxypeptidase R, procarboxypeptidase U) 显示文摘	Bouma B N Marx P F Mosnier L O	2001	Thromb Res2001，101，5：	1
3	The cytoprotec- tive protein C pathway 显示文摘	Mosnier L O Zlokovic B V Griffin J H	2007	Blood2007，109，8：	1
4	The cytoprotective protein C pathway显示文摘	MOSNIER L O ZLOKOVIC B V GRIFFIN J H	2007	Blood2007，109，8：	1
5	Regulation of fibrinolysis in plasma by TAFI and protein C is dependent on the concentration of thrombomodulin显示文摘	Mosnier L O Meijers J C Bouma B N	2001	Thromb Haemost2001，85，1：	1
6	Thrombinactivatable fibrinolysis inhibitor deft ciency in cirrhosis is not associated with increased plasma fi- brinotysis 显示文摘	LISMAN T LEEBEEK F W MOSNIER L O	2001	Gastroenterology2001，121，：	1
7	Plasma TAFI level influence the clotlysis time in healthy individuals in the presence of an intact intrinsic pathway of coagulation显示文摘	Mosnier L O von dem Borne P A Meijers J C	1998	Thromb Haemost1998，80，5：	1
8	Reduced ae- tivity of TAFI(thrornbin activatable fibrinolysis inhibitor) in acute promyelocytie Ieukaemia显示文摘	Meiiers J C Oudiik E J Mosnier L O	2000	Br J Haematol2000，108，3：	1
9	Zn^2+-contai- ning protein S inhibits extrinsic factor X-activating com- plex independently of tissue factor pathway inhibitor显示文摘	Fernandes N Mosnier LO Tonnu L	2010	J Thromb Haemost2010，8，9：	1
10	Reduced activity of TAFI(thrombin-activatable fibrinolysis inhibitor)in acute promyelocytic leukaemia显示文摘	Meijers J C Oudijk E J Mosnier L O	2000	Br J Haematol2000，108，3：	1
11	Zn2-containing protein S inhibits extrinsic factor X-activating complex independently of tissue factor pathway inhibitor显示文摘	Fernandes N Mosnier LO Tonnu L	2010	J Thromb Haemost2010，8，9：	1
12	Cell paintingwith an engineered EPCR to augment the protein C system显示文摘	Bouwens E A Stavenuiter F Mosnier L 0	2015	Thromb Haemost2015，114，6：	1
13	Protein C anticoagulant activity in relation to anti - inflammatory and anti - apoptotie activities 显示文摘	MOSNIER L O GRIFFIN J H	2006	Front Biosci2006，11，：	1
14	Thrombin-activatable fibrinolysis inhibitor (TAFI, plasma procarboxypeptidase B,procarboxypeptidase R,procarboxypeptidase U)显示文摘	Bouma B N Marx P F Mosnier L O	2001	Res2001，101，5：	1
15	Long-term functional outcome in facial nerve graft by fibrin glue in the temporal bone and cerebellopontine angle显示文摘	Bozorg Grayeli A Mosnier L Julie N	2005	Eur Arch Otorhinolaryngol2005，262，5：	1
16	Carcinoma associated paraneoplastic peripheral neuropathies in patients with and without anti-onconeural antibodies显示文摘	Antoine JC Mosnier JF Absi L	1999	J Neurol Neurosurg Psychiatry1999，67，：	1
17	Factor XI dependent and independent activation of thrombin activatable fibrinolysis inhibitor(TAFI) in plasma associated with clot formation显示文摘	Bouma B N Mosnier L O Meijers J C		0，，06：	1
18	Zn2+ containing pro- tein S inhibits extrinsic factor pathway inhibitor 显示文摘	Fernandes N Mosnier LO Tonnu L etal	2010	J Thromb Haemost2010，8，：	1
19	Reduced activity of TAFI (thrombin-activatable fibrinolysis inhibitor) in acute promyelocytic leukaemia 显示文摘	MEIJERS J C OUDIJK E J MOSNIER L O	2000	Br J Haematol2000，108，：	1
20	Thrombinactivatable fibrinolysis inhibitor deft ciency in cirrhosis is not associated with increased plasma fibrinolysis显示文摘	Lisman T Leebeek F W Mosnier L O		0，，01：	1

返回顶部每页显示：

共2页首页上一页第1页下一页末页 /2 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示